Title | Journal of Advanced Biotechnology and Experimental Therapeutics |
Abbreviation | J. Adv. Biotechnol. Exp. Ther. |
Publication Type | Journal |
Subject Area, Categories, Scope | Applied Microbiology and Biotechnology (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Plant Science (Q3) |
h-index | 10 |
Overall Rank/Ranking | 16899 |
SCImago Journal Rank (SJR) | 0.266 |
Impact Score | 1.42 |
Publisher | Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology |
Country | Bangladesh |
ISSN | 26164760 |
Best Quartile | Q3 |
Coverage History | 2018-2023 |
Journal of Advanced Biotechnology and Experimental Therapeutics is a journal covering the technologies/fields/categories related to Applied Microbiology and Biotechnology (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Plant Science (Q3). It is published by Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology. The overall rank of Journal of Advanced Biotechnology and Experimental Therapeutics is 16899. According to SCImago Journal Rank (SJR), this journal is ranked 0.266. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 10. The best quartile for this journal is Q3.
The ISSN of Journal of Advanced Biotechnology and Experimental Therapeutics journal is 26164760. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Advanced Biotechnology and Experimental Therapeutics is cited by a total of 178 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of Advanced Biotechnology and Experimental Therapeutics is 1.42, which is computed in 2024 as per its definition. Journal of Advanced Biotechnology and Experimental Therapeutics IF is increased by a factor of 0.14 and approximate percentage change is 10.94% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of Advanced Biotechnology and Experimental Therapeutics is 1.42. If the same upward trend persists, Impact IF may rise in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 1.42 |
2022 | 1.28 |
2021 | 0.93 |
2020 | 0.32 |
2019 | 0.38 |
2018 | 0.00 |
Journal of Advanced Biotechnology and Experimental Therapeutics has an h-index of 10. It means 10 articles of this journal have more than 10 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Advanced Biotechnology and Experimental Therapeutics is 26164760. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Advanced Biotechnology and Experimental Therapeutics is 16899. According to SCImago Journal Rank (SJR), this journal is ranked 0.266. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.266 |
2022 | 0.205 |
2021 | 0.155 |
2020 | |
2019 | |
2018 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 16899 |
2022 | 18935 |
2021 | 20864 |
2020 | 33739 |
2019 | 31380 |
2018 | 32879 |
Journal of Advanced Biotechnology and Experimental Therapeutics is published by Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology. It's publishing house is located in Bangladesh. Coverage history of this journal is as following: 2018-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Advanced Biotechnology and Experimental Therapeutics is J. Adv. Biotechnol. Exp. Ther.. This abbreviation ('J. Adv. Biotechnol. Exp. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Applied Microbiology and Biotechnology (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Plant Science (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Advanced Biotechnology and Experimental Therapeutics latest impact IF is 1.42. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 1.42 (2023) and 0.00 (2018), respectively, in the last 6 years. Moreover, its average IS is 0.72 in the previous 6 years.
The Journal of Advanced Biotechnology and Experimental Therapeutics has an SJR (SCImago Journal Rank) of 0.266, according to the latest data. It is computed in the year 2024. In the past 6 years, this journal has recorded a range of SJR, with the highest being 0.266 in 2023 and the lowest being in 2020. Furthermore, the average SJR of the Journal of Advanced Biotechnology and Experimental Therapeutics over the previous 6-year period stands at 0.72.
The latest h-index of the Journal of Advanced Biotechnology and Experimental Therapeutics is 10.
The Journal of Advanced Biotechnology and Experimental Therapeutics is published by the Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology, with its country of publication being the Bangladesh.
The Journal of Advanced Biotechnology and Experimental Therapeutics is currently ranked 16899 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 6 years, this journal has experienced varying rankings, reaching its highest position of 16899 in 2023 and its lowest position of 33739 in 2020.
The standard ISO4 abbreviation for the Journal of Advanced Biotechnology and Experimental Therapeutics is J. Adv. Biotechnol. Exp. Ther..
Journal of Advanced Biotechnology and Experimental Therapeutics is classified as a journal that the Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology publishes.
The Journal of Advanced Biotechnology and Experimental Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Advanced Biotechnology and Experimental Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 26164760.
The best quartile for the Journal of Advanced Biotechnology and Experimental Therapeutics is Q3 (2023).
The Journal of Advanced Biotechnology and Experimental Therapeutics coverage history can be summarized as follows: 2018-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Journal of Academic Ethics | journal | 10291 | Springer Netherlands | 30 | 2.62 |
Applied Ecology and Environmental Research | journal | 18145 | Corvinus University of Budapest | 43 | 0.77 |
Abacus | journal | 5997 | Wiley-Blackwell Publishing Ltd | 53 | 2.75 |
Journal of Education and Work | journal | 11494 | Brill Academic Publishers | 45 | 2.17 |
Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
Journal of Sociology | journal | 5238 | SAGE Publications Ltd | 62 | 2.22 |
Metascience | journal | 24313 | Springer Nature | 3 | 0.00 |
Cuadernos de historia (Santiago, Chile) | journal | 19650 | Universidad de Chile | 5 | 0.17 |
International Journal of Organizational Analysis | journal | 5983 | Emerald Group Publishing Ltd. | 41 | 5.28 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 1.42 |
2022 | 1.28 |
2021 | 0.93 |
2020 | 0.32 |
2019 | 0.38 |
2018 | 0.00 |